Sign inJoin waitlistJoin the waitlist

DR

David Riley

Pulmonary Disease

Credentials: ·

History

Pulmonary Disease
Internal Medicine

Research

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
The Lancet Respiratory Medicine · 2016 · 831 citations
Prevention of collagen deposition following pulmonary oxygen toxicity in the rat by cis-4-hydroxy-L-proline
Review · Journal of Clinical Investigation · 1980 · First of 4 authors · 69 citations
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study
Arthritis & Rheumatism · 2007 · 69 citations

Norman Edelman
6 papers
BI
Barbara Ianni
3 papers
GP
George Poiani
3 papers · 1 as a fellow
Arthur Theodore
2 papers
Bob Wise
2 papers
Charles Read
2 papers
CC
Claudia Chae
2 papers
Daniel Furst
2 papers
DS
Dean Schraufnagel
2 papers
Dinesh Khanna
2 papers
Donald Tashkin
2 papers
Fredrick Wigley
2 papers